Fibrogen Inc financial data

Symbol
FGEN on Nasdaq
Industry
Pharmaceutical Preparations
Location
409 Illinois Street, San Francisco, California
State of incorporation
Delaware
Fiscal year end
December 31
Latest financial report
Q1 2024 - May 6, 2024

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 169 % -9.89%
Quick Ratio 18.4 % +14.9%
Debt-to-equity -331 % -109%
Return On Equity 158 %
Return On Assets -54.5 % -8.42%
Operating Margin -191 % +10.8%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 99.5 M shares +1.94%
Common Stock, Shares, Outstanding 99.5 M shares +2.95%
Entity Public Float 262 M USD -73.2%
Common Stock, Value, Issued 995 K USD +3%
Weighted Average Number of Shares Outstanding, Basic 99 M shares +4.53%
Weighted Average Number of Shares Outstanding, Diluted 99 M shares +4.53%

Income Statement

Label TTM Value / Value Unit Change %
Revenues 148 M USD +4.99%
Revenue from Contract with Customer, Excluding Assessed Tax 167 M USD +44.3%
Cost of Revenue 41.1 M USD +110%
Research and Development Expense 247 M USD -12.6%
Costs and Expenses 404 M USD -6.02%
Operating Income (Loss) -237 M USD +24.6%
Nonoperating Income (Expense) 12 M USD +34.2%
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest -287 M USD +2.71%
Income Tax Expense (Benefit) -38 K USD -112%
Net Income (Loss) Attributable to Parent -240 M USD +21.7%
Earnings Per Share, Basic -2.44 USD/shares +25.4%
Earnings Per Share, Diluted -2.44 USD/shares +25.4%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value 106 M USD -43.9%
Accounts Receivable, after Allowance for Credit Loss, Current 37.1 M USD +110%
Inventory, Net 27.3 M USD -35.6%
Other Assets, Current 1.87 M USD
Assets, Current 278 M USD -35.4%
Property, Plant and Equipment, Net 12.2 M USD -34.9%
Operating Lease, Right-of-Use Asset 64.8 M USD -15.6%
Other Assets, Noncurrent 3.35 M USD -28.3%
Assets 366 M USD -32.1%
Accounts Payable, Current 4.35 M USD -93.9%
Employee-related Liabilities, Current 7.4 M USD -39.5%
Accrued Liabilities, Current 164 M USD +4.61%
Contract with Customer, Liability, Current 12.9 M USD -22%
Liabilities, Current 197 M USD -22.8%
Contract with Customer, Liability, Noncurrent 147 M USD -9.79%
Operating Lease, Liability, Noncurrent 62.5 M USD -18.7%
Other Liabilities, Noncurrent 3.79 M USD -46.4%
Liabilities 552 M USD -2.72%
Accumulated Other Comprehensive Income (Loss), Net of Tax -6.51 M USD -42.4%
Retained Earnings (Accumulated Deficit) -1.87 B USD -14.7%
Stockholders' Equity Attributable to Parent -228 M USD -367%
Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest -208 M USD -619%
Liabilities and Equity 366 M USD -32.1%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities -59.3 M USD +41.6%
Net Cash Provided by (Used in) Financing Activities -165 K USD -101%
Net Cash Provided by (Used in) Investing Activities 51.3 M USD -50.4%
Common Stock, Shares Authorized 225 M shares 0%
Common Stock, Shares, Issued 99.5 M shares +2.95%
Common Stock, Par or Stated Value Per Share 0.01 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect -7.95 M USD -124%
Interest Paid, Excluding Capitalized Interest, Operating Activities 54 K USD -48.1%
Deferred Tax Assets, Valuation Allowance 535 M USD +11.9%
Effective Income Tax Rate Reconciliation, at Federal Statutory Income Tax Rate, Percent 0.21 pure 0%
Deferred Tax Assets, Gross 549 M USD +11.6%
Operating Lease, Liability 77.7 M USD -10.5%
Depreciation 810 K USD -68.1%
Payments to Acquire Property, Plant, and Equipment 29 K USD -95.1%
Comprehensive Income (Loss), Net of Tax, Attributable to Parent -242 M USD +20.6%
Lessee, Operating Lease, Liability, to be Paid 90.3 M USD -12.7%
Property, Plant and Equipment, Gross 150 M USD +0.52%
Operating Lease, Liability, Current 15.2 M USD +53.4%
Lessee, Operating Lease, Liability, to be Paid, Year Two 18.8 M USD +8.87%
Lessee, Operating Lease, Liability, to be Paid, Year One 17.6 M USD +26.2%
Operating Lease, Weighted Average Discount Rate, Percent 0.05 pure 0%
Deferred Income Tax Expense (Benefit) 0 USD
Lessee, Operating Lease, Liability, Undiscounted Excess Amount 9.74 M USD -28.7%
Lessee, Operating Lease, Liability, to be Paid, Year Three 18.1 M USD -1.98%
Deferred Tax Assets, Operating Loss Carryforwards 175 M USD +5.13%
Preferred Stock, Shares Issued 0 shares
Deferred Federal Income Tax Expense (Benefit) 0 USD
Current Income Tax Expense (Benefit) 3 K USD -99.2%
Preferred Stock, Shares Authorized 125 M shares 0%
Unrecognized Tax Benefits 81 M USD +11.3%
Lessee, Operating Lease, Liability, to be Paid, Year Four 18.5 M USD +2.64%
Operating Lease, Payments 14.5 M USD -6.67%
Additional Paid in Capital 1.65 B USD +3.97%
Preferred Stock, Shares Outstanding 0 shares
Current State and Local Tax Expense (Benefit) 0 USD
Current Federal Tax Expense (Benefit) 0 USD
Deferred Tax Assets, Net of Valuation Allowance 14 M USD -0.27%
Share-based Payment Arrangement, Expense 50.8 M USD -22.6%
Deferred State and Local Income Tax Expense (Benefit) 0 USD
Interest Expense 18.2 M USD +389%
Preferred Stock, Par or Stated Value Per Share 0.01 USD/shares 0%